GCA becomes part of Houlihan Lokey
Home » Transactions » GCA Advises Harbin Pharma on Its Acquisition of Roxatidine China Rights from ASKA Pharma
Transaction Details
Closed
December 23, 2020
Sector
Healthcare
GCA Advises Harbin Pharma on Its Acquisition of Roxatidine China Rights from ASKA Pharma
All Transactions